Fertility and Sterility
Volume 92, Issue 4 , Pages 1366-1368, October 2009

Perifollicular blood flow and pregnancy in superovulated intrauterine insemination (IUI) cycles: An observational comparison of recombinant follicle-stimulating hormone (FSH) and urinary gonadotropins

  • Amanda J. O'Leary, MBChB., MRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • Corresponding Author InformationReprint requests: Amanda J. O'Leary.
    • ,
  • Anthony N. Griffiths, MBBCh., MRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • ,
  • Janet Evans, MBBCh., FRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • ,
  • Neil D. Pugh, MBBCh., MRCR.

      Affiliations

    • Department of Medical Physics and Bioengineering, University Hospital of Wales, Heath Park, Cardiff, United Kingdom

Received 22 May 2007; received in revised form 31 January 2009; accepted 18 February 2009. published online 07 April 2009.

The group of patients who received urinary gonadotropins (n = 117) for follicular stimulation had a significantly higher incidence of high perifollicular blood flow compared with that of the group who received recombinant FSH (n = 114; 46.3% vs. 22.7%). The overall clinical pregnancy rate in patients stimulated with recombinant FSH was 10.91%, compared with 22.22% in the group stimulated with urinary gonadotropins.

Key Words: Gonadotropins, intrauterine insemination, perifollicular blood flow, transvaginal power Doppler

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A.J.O. has nothing to disclose. A.N.G. has nothing to disclose. J.E. has nothing to disclose. N.D.P. has nothing to disclose.

PII: S0015-0282(09)00465-8

doi:10.1016/j.fertnstert.2009.02.046

Fertility and Sterility
Volume 92, Issue 4 , Pages 1366-1368, October 2009

Article Tools